1. Serum Hepcidin Levels, Iron Dyshomeostasis and Cognitive Loss in Alzheimer#cod#x02019;s Disease
Zohara Sternberg 1 ;Zihua Hu 2 ;Daniel Sternberg 1 ;Shayan Waseh 3 ;Joseph F. Quinn 4 ;Katharine Wild 4 ;Kaye Jeffrey 4 ;Lin Zhao 5 ;Michael Garrick 5, 6 ;
1 Department of Neurology, Stroke Center, Buffalo Medical Center, Buffalo, NY, USA. ; 2 Center for Computational Research, New York State Center for Excellence in Bioinformatics and Life Sciences, University at Buffalo, Buffalo, NY, USA. ; 3 Department of Biology, State University of New York at Buffalo, Buffalo, NY USA. ; 4 Layton Aging #cod#x00026; Alzheimer#cod#x00027;s Research Center, Oregon Health and Science University, Portland, Oregon, USA. ; 5 Department of Biochemistry, State University of New York at Buffalo, Buffalo, NY USA. ; 6 Department of Pediatrics, State University of New York at Buffalo, Buffalo, NY USA. ;
Figure Correlations between measurements depend on diagnosis . For each panel, lines of regression indicate the existence or absence of a correlation and the shaded region shows the 95#cod#x00025; confidence interval CI with data stratified by diagnosis of AD or control for hepcidin versus iron A, hepcidin versus TIBC B, hepcidin versus ferritin C, and A#cod#x003B2; 40 versus A#cod#x003B2; 42 D.
Aging and Disease,null,8(2), Doi: /AD